Browsing Tag
LENZ Therapeutics Inc.
1 post
LENZ Therapeutics (NASDAQ: LENZ) cuts 75% of jobs after VIZZ Q3 sales reach $2.6m
LENZ Therapeutics is cutting three-quarters of its workforce and changing CEOs despite accelerating VIZZ prescriptions, betting that a much smaller organisation can market its new presbyopia drug more efficiently.